SI1613300T1 - Fotostabilizirane topiäśne formulacije ketoprofena, vsebujoäśe dva uv filtra - Google Patents

Fotostabilizirane topiäśne formulacije ketoprofena, vsebujoäśe dva uv filtra

Info

Publication number
SI1613300T1
SI1613300T1 SI200431048T SI200431048T SI1613300T1 SI 1613300 T1 SI1613300 T1 SI 1613300T1 SI 200431048 T SI200431048 T SI 200431048T SI 200431048 T SI200431048 T SI 200431048T SI 1613300 T1 SI1613300 T1 SI 1613300T1
Authority
SI
Slovenia
Prior art keywords
filters
photostabilized
topical formulations
skin
ketoprofen
Prior art date
Application number
SI200431048T
Other languages
English (en)
Inventor
Karsten Groger
Carlo Alberto Maggi
Stefano Manzini
Reinhard Schmitz
Marc Wihsmann
Original Assignee
Berlin Chemie Ag
Menarini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin Chemie Ag, Menarini Ricerche Spa filed Critical Berlin Chemie Ag
Publication of SI1613300T1 publication Critical patent/SI1613300T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SI200431048T 2003-03-18 2004-03-17 Fotostabilizirane topiäśne formulacije ketoprofena, vsebujoäśe dva uv filtra SI1613300T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000070A ITFI20030070A1 (it) 2003-03-18 2003-03-18 Formulazioni topiche stabilizzate contenenti ketoprofene
EP04721199A EP1613300B1 (en) 2003-03-18 2004-03-17 Photostabilized topical formulations of ketoprofen containing two uv filters
PCT/EP2004/050317 WO2004082580A2 (en) 2003-03-18 2004-03-17 Photostabilized topical formulations of ketoprofen containing two uv filters

Publications (1)

Publication Number Publication Date
SI1613300T1 true SI1613300T1 (sl) 2009-06-30

Family

ID=33017958

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200431048T SI1613300T1 (sl) 2003-03-18 2004-03-17 Fotostabilizirane topiäśne formulacije ketoprofena, vsebujoäśe dva uv filtra

Country Status (20)

Country Link
EP (1) EP1613300B1 (sl)
KR (1) KR20060008869A (sl)
CN (1) CN1767824A (sl)
AT (1) ATE416763T1 (sl)
CY (1) CY1108869T1 (sl)
DE (1) DE602004018291D1 (sl)
DK (1) DK1613300T3 (sl)
ES (1) ES2321837T3 (sl)
IT (1) ITFI20030070A1 (sl)
MA (1) MA27669A1 (sl)
MX (1) MXPA05009902A (sl)
MY (1) MY140025A (sl)
PL (1) PL1613300T3 (sl)
PT (1) PT1613300E (sl)
RU (1) RU2340335C2 (sl)
SI (1) SI1613300T1 (sl)
TW (1) TWI327912B (sl)
UA (1) UA82871C2 (sl)
WO (1) WO2004082580A2 (sl)
ZA (1) ZA200508153B (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ576992A (en) * 2006-10-27 2011-02-25 Noven Pharma Transdermal delivery of ketoprofen polar derivatives
EP2153815A1 (en) 2008-08-05 2010-02-17 Isdin S.A. Use of urea containing compositions
EP2153814A1 (en) 2008-08-05 2010-02-17 Isdin S.A. Use of compositions comprising urea
JP5123333B2 (ja) 2010-01-26 2013-01-23 株式会社 資生堂 油中水型乳化日焼け止め化粧料
CN102068405A (zh) * 2010-12-16 2011-05-25 天津工业大学 一种酮洛芬凝胶及其制备方法
WO2013022410A2 (en) 2011-08-08 2013-02-14 Mahmut Bilgic Production method for effervescent formulations comprising dexketoprofen
US8822537B2 (en) * 2012-09-27 2014-09-02 Achelios Therapeutics, Inc. Topical ketoprofen composition
CN103804184B (zh) * 2014-02-14 2016-02-03 南京科胜医药科技有限公司 精氨酸酮洛芬的晶型及制备方法
RU2667465C2 (ru) * 2015-10-28 2018-09-19 Закрытое Акционерное Общество "Фармфирма "Сотекс" Фармацевтическая композиция для наружного применения, содержащая соль декскетопрофена, и способ ее получения

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60155111A (ja) * 1983-10-20 1985-08-15 Hisamitsu Pharmaceut Co Inc 安定なケトプロフェン含有外用経皮製剤
WO1992005768A1 (en) * 1990-10-05 1992-04-16 Analgesic Associates Prevention or treatment of sunburn using the s(+) isomer of flurbiprofen
KR930701977A (ko) * 1990-10-05 1993-09-08 원본미기재 케토프로펜의 s(＋) 이성질체를 이용한 일조화상(日照火傷)의 예방 및 치료
US5185373A (en) * 1991-08-13 1993-02-09 American Home Products Corporation Inhibition of thermal degradation of ibuprofen
DE4444238A1 (de) * 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
FR2804024B1 (fr) * 2000-01-21 2002-09-13 Menarini France Nouvelles compositions pharmaceutiques a action anti- inflammatoire et leur procede de preparation
BRPI0109198B8 (pt) * 2000-03-17 2021-05-25 Hisamitsu Pharmaceutical Co emplastro tendo um apoio

Also Published As

Publication number Publication date
PT1613300E (pt) 2009-03-27
CY1108869T1 (el) 2014-07-02
ES2321837T3 (es) 2009-06-12
MXPA05009902A (es) 2006-03-21
KR20060008869A (ko) 2006-01-27
ITFI20030070A1 (it) 2004-09-19
EP1613300B1 (en) 2008-12-10
ATE416763T1 (de) 2008-12-15
DK1613300T3 (da) 2009-03-09
PL1613300T3 (pl) 2009-05-29
RU2340335C2 (ru) 2008-12-10
CN1767824A (zh) 2006-05-03
MY140025A (en) 2009-11-30
DE602004018291D1 (de) 2009-01-22
WO2004082580A3 (en) 2005-01-27
TWI327912B (en) 2010-08-01
MA27669A1 (fr) 2005-12-01
TW200509897A (en) 2005-03-16
RU2005132004A (ru) 2006-02-27
UA82871C2 (en) 2008-05-26
WO2004082580A2 (en) 2004-09-30
ZA200508153B (en) 2007-10-31
EP1613300A2 (en) 2006-01-11

Similar Documents

Publication Publication Date Title
CY1108869T1 (el) Φωτοσταθεροποιημενα τοπικα σκευασματα κετοπροφαινης που περιεχουν δυο φιλτρα uv
WO2007096601A3 (en) Antimicrobial formulations comprising a quinone and a copper salt
WO2004017920A3 (en) Novel biphenyl and biphenyl-like cannabinoids
MY142589A (en) Benzimidazole derivatives : preparation and pharmaceutical applications
NO20060416L (no) Ny anvendelse I
WO2005016286A8 (en) Pyrazine modulators of cannabinoid receptors
WO2004105722A8 (en) A formulation for chemical peeling
HK1079446A1 (en) Pharmeceutical solid dispersions of modafinil compounds
WO2004055006A8 (en) Novel compounds having selective inhibiting effect at gsk3
WO2009072007A3 (en) Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2006069998A3 (de) Glycopyrrolat in kosmetischen zubereitungen
WO2010009892A3 (en) Compositions for the treatment of pain and/or inflamation
ES2124983T5 (es) Utilizacion de un antagonista de substancia p para el tratamiento de las manchas rojas cutaneas de origen neurogeno.
CA2441461A1 (en) Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia
WO2005016249A3 (en) Compositions of a chromene or phenyl acetic acid cyclooxygenase-2 selective inhibitor and an ace inhibitor for the treatment of central nervous system damage
WO2003092655A3 (de) Verwendung von wirkstoffmischungen mit azelainsaure und glycyrrhetinsaure als anti-aknemittel
TW200507838A (en) Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator
MY139295A (en) Stabilised topical formulations containing ketoprofen
WO2004093816A3 (en) Compositions comprising a selective cox-2 inhibitor and a calcium modulating agent
DK1666473T3 (da) Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens
WO2004098522A3 (en) Gemini vitamin d3 compounds and methods of use thereof
WO2003061572A8 (en) Anti-inflammatory formulations
MXPA05008243A (es) Formulacion mejorada para agentes aclarantes de la piel.
EP1273301A3 (en) Pharmaceutical preparations based on active ingredients susceptible to illict administration
WO2004105699A3 (en) Compositions of a cyclooxygenase-2 selective inhibitor and a cannabinoid agent for the treatment of central nervous system damage